IDiyas

For the Inventor, By the Inventor

Littleton, MA, United States of America

William E Yelle

USPTO Granted Patents = 18

Average Co-Inventor Count = 1.3

ph-index = 4

Forward Citations = 44(Granted Patents)


Location History:

  • Littleton, MA (US) (2000 - 2006)
  • Billerica, MA (US) (2006)

Company Filing History:

goldMedal18 out of 322 
 
Sepracor, Inc.
 patents

Years Active: 2000-2006

Loading Chart...
18 patents (USPTO):
1. 7098224 - Hydroxylansoprazole methods (2006-08-29),
2. 7030142 - Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites (2006-04-18),
3. 6500833 - (+)-Hydroxyrisperidone compositions and methods (2002-12-31),
4. 6498171 - Hydroxyomeprazole compositions (2002-12-24),
5. 6468997 - Desmethylolanzapine compositions and methods (2002-10-22),
6. 6465470 - R-hydroxynefazodone (2002-10-15),
7. 6465469 - S-hydroxynefazodone (2002-10-15),
8. 6384037 - R-hydroxynefazodone (2002-05-07),
9. 6352984 - Olanzapine-N-oxide compositions and methods (2002-03-05),
10. 6348455 - Desmetylolanzapine compositions and methods (2002-02-19),
11. 6346528 - 2-Hydroxymethylolanzapine compositions and methods (2002-02-12),
12. 6342488 - Phosphonorisperidone and sulforisperidone compositions and methods (2002-01-29),
13. 6335351 - Hydroxylansoprazole compositions and methods (2002-01-01),
14. 6326362 - (-)-phosphonorisperidone and (-)-sulforisperidone compositions and methods (2001-12-04),
15. 6294586 - Hydroxyomeprazole compositions and methods (2001-09-25),

Title: Innovations and Contributions of William E. Yelle

Introduction

William E. Yelle is a notable inventor based in Littleton, MA (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 18 patents to his name, Yelle has made remarkable advancements in medical treatments, particularly in addressing gastric and neuroleptic disorders.

Latest Patents

Among his latest patents is the invention of Hydroxylansoprazole methods. This innovation involves methods and compositions utilizing hydroxylansoprazole for the treatment of ulcers in humans. Hydroxylansoprazole is noted for its reduced liability toward drug-drug interactions compared to lansoprazole, as well as a more predictable dosing regimen. Additionally, it is effective for treating gastroesophageal reflux and conditions related to gastric hypersecretion, such as Zollinger-Ellison Syndrome. Another significant patent involves methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites. This invention encompasses novel methods and pharmaceutical compositions that are suitable for treating neuroleptic disorders, along with methods for preparing ziprasidone sulfoxide and ziprasidone sulfone.

Career Highlights

William E. Yelle has made substantial contributions during his career, particularly while working at Sepracor, Inc. His work has focused on developing innovative solutions that enhance patient care and treatment efficacy.

Collaborations

Yelle has collaborated with esteemed colleagues, including Paul D. Rubin and Timothy J. Barberich, to further advance his research and innovations in the pharmaceutical field.

Conclusion

William E. Yelle's contributions to medical science through his patents and collaborations highlight his dedication to improving healthcare solutions. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…